We are one of the leading service providers for business development in emerging markets. We are an independent and privately owned group of companies headquartered in Austria since 1994.

We believe in long-lasting partnerships, provide end-to-end supply chain solutions, and support our clients with customized finance models.

Risk is an inherent part of our business activity and its management is fundamental to our success. We have established a solid reputation with banks, other financial institutions and our customers with more than 30 years of experience and extensive know-how for market access and business growth in a complex and changing market environment.

Examon Group consists of companies located in Austria. Our main area of business is trading, business development and financing for the pharmaceutical market. In addition, we invest in real estate in Austria to secure and balance our portfolio.

Associated Companies 

EXAMON HANDLSGES M.B.H; registered and located in Austria since 1994 specializes in trade and finance for pharmaceutical products and the healthy food industry. In addition, we offer Regulatory Affairs services as well as Sales & Marketing support in the Middle East.

EXAMON PHARMA HANDELSGES M.B.H; registered and located in Austria is a trading company for pharmaceutical products from companies which we represent.

EXAMON REAL ESTATE GMBH; registered and located in Austria invests in Real Estate in Western Europe.

EXAMON INVESTMENT GMBH; registered and located in Austria is an investment company that invests in real estate and premium companies in Europe.

EXAMON TURKEY YÖNETİM DANIŞMANLIĞI ANONİM ŞİRKETİ; This is Examon new strategy to look for investment opportunities in the financial instruments, especially in emerging markets. Turkey with a remarkable rate of growth after the 1980s became the 17th largest economy in the world and the 6th largest economy compared with EU countries in 2017. Robust economic growth with an average annual real GDP growth of 5.6 percent during 2003-2016 and achieving a GDP of USD 849,48 billion in 2017, up from USD 236 billion in 2002 were consequences of the following economic reforms:

• Economy liberalization and shifting from agriculture towards industrial and service activities;

• Modernization of the existing industries and technology transfer;

• Facilitating international trade and absorbing foreign investments and

• Sound economic policies with a prudent fiscal discipline and strong financial structure resilient to the global financial crisis.

EXAMON TURKEY YÖNETİM DANIŞMANLIĞI ANONİM ŞİRKETİ will primarily focus on investing in the financial instruments registered in the Istanbul Stock Exchange such as shares, derivatives, mutual funds, governmental bonds, etc. for the sole purpose of utilizing the available Examon funds for gaining financial returns. In further steps, our Turkish establishment will work on other business opportunities such as exporting Turkish manufacturing products to the EU and the Middle East.